Talkspace (TALK) Competitors $3.14 +0.01 (+0.32%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TALK vs. WGS, USPH, PNTG, INNV, SHCR, DCGO, PIII, EUDA, ATPC, and KDLYShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include GeneDx (WGS), U.S. Physical Therapy (USPH), The Pennant Group (PNTG), InnovAge (INNV), Sharecare (SHCR), DocGo (DCGO), P3 Health Partners (PIII), EUDA Health (EUDA), Agape ATP (ATPC), and Kindly MD (KDLY). These companies are all part of the "health services" industry. Talkspace vs. GeneDx U.S. Physical Therapy The Pennant Group InnovAge Sharecare DocGo P3 Health Partners EUDA Health Agape ATP Kindly MD GeneDx (NASDAQ:WGS) and Talkspace (NASDAQ:TALK) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings. Do analysts rate WGS or TALK? GeneDx presently has a consensus price target of $59.33, indicating a potential downside of 23.68%. Talkspace has a consensus price target of $3.00, indicating a potential downside of 4.46%. Given Talkspace's higher possible upside, analysts plainly believe Talkspace is more favorable than GeneDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeneDx 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Talkspace 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders hold more shares of WGS or TALK? 61.7% of GeneDx shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 27.3% of GeneDx shares are held by company insiders. Comparatively, 21.7% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is WGS or TALK more profitable? Talkspace has a net margin of -0.76% compared to GeneDx's net margin of -31.25%. Talkspace's return on equity of -1.17% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets GeneDx-31.25% -13.35% -6.91% Talkspace -0.76%-1.17%-0.99% Which has more volatility & risk, WGS or TALK? GeneDx has a beta of 2.32, indicating that its stock price is 132% more volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Which has stronger valuation & earnings, WGS or TALK? Talkspace has lower revenue, but higher earnings than GeneDx. Talkspace is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeneDx$202.57M10.34-$175.77M-$3.11-25.00Talkspace$181.29M2.91-$19.18M-$0.01-314.00 Does the media prefer WGS or TALK? In the previous week, GeneDx had 2 more articles in the media than Talkspace. MarketBeat recorded 31 mentions for GeneDx and 29 mentions for Talkspace. GeneDx's average media sentiment score of 0.53 beat Talkspace's score of 0.51 indicating that GeneDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeneDx 7 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Talkspace 7 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Does the MarketBeat Community favor WGS or TALK? GeneDx received 10 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 47.62% of users gave GeneDx an outperform vote while only 0.00% of users gave Talkspace an outperform vote. CompanyUnderperformOutperformGeneDxOutperform Votes1047.62% Underperform Votes1152.38% TalkspaceOutperform VotesNo VotesUnderperform Votes7100.00% SummaryGeneDx beats Talkspace on 12 of the 18 factors compared between the two stocks. Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$528.19M$890.51M$5.40B$8.53BDividend YieldN/A2.20%5.13%4.14%P/E Ratio-314.0031.61113.4615.10Price / Sales2.914.111,484.4093.54Price / CashN/A23.3739.6434.05Price / Book4.423.044.655.02Net Income-$19.18M-$10.72M$119.06M$225.46M7 Day Performance12.95%7.17%0.79%0.37%1 Month Performance33.62%13.71%5.65%3.57%1 Year Performance82.56%335.66%36.76%29.42% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace1.4176 of 5 stars$3.14+0.3%$3.00-4.5%+74.4%$528.19M$181.29M-314.00472Earnings ReportAnalyst ForecastAnalyst RevisionWGSGeneDx1.3856 of 5 stars$77.74-4.8%$59.33-23.7%+4,035.1%$2.09B$202.57M-25.001,200Earnings ReportAnalyst ForecastInsider SellingNews CoverageGap DownHigh Trading VolumeUSPHU.S. Physical Therapy3.9428 of 5 stars$81.38+1.5%$105.00+29.0%-1.9%$1.23B$627.67M76.776,720Upcoming EarningsNews CoveragePNTGThe Pennant Group4.0501 of 5 stars$32.49+1.6%$37.50+15.4%+202.2%$984.77M$544.89M51.575,791Upcoming EarningsINNVInnovAge0.4133 of 5 stars$5.93+2.2%$6.50+9.6%+14.5%$803.52M$763.85M-37.062,350Upcoming EarningsShort Interest ↑News CoverageSHCRSharecare0.9253 of 5 stars$1.43flat$1.43N/A$531.79M$445.25M-3.673,352DCGODocGo1.7759 of 5 stars$3.63+3.4%$6.10+68.0%-40.4%$371.42M$624.29M12.964,164Upcoming EarningsNews CoveragePIIIP3 Health Partners2.3491 of 5 stars$0.37+2.8%$4.50+1,122.8%-74.4%$131.64M$1.27B-0.57500EUDAEUDA Health1.6379 of 5 stars$4.24-0.2%N/A+311.7%$104.43M$3.71M0.002Positive NewsATPCAgape ATPN/A$1.69-0.6%N/A-90.4%$6.51M$1.43M-2.8240Gap UpKDLYKindly MDN/A$0.97-4.0%N/AN/A$5.77MN/A0.00N/ANews Coverage Related Companies and Tools Related Companies GeneDx Competitors U.S. Physical Therapy Competitors The Pennant Group Competitors InnovAge Competitors Sharecare Competitors DocGo Competitors P3 Health Partners Competitors EUDA Health Competitors Agape ATP Competitors Kindly MD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TALK) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
